Innovation Fusion, New Desheng Leap - Hubei New Desheng is about to land on the 93rd CMEF

From April 9th to 12th, 2026, the 93rd China International Medical Equipment Fair (CMEF) Spring Exhibition, the "barometer" event of the global medical and health industry, will be held grandly at the Shanghai National Convention and Exhibition Center. The theme of this exhibition is "Innovation Fusion, Infinite Leap", with a total scale of over 320000 square meters, gathering nearly 5000 brand enterprises from more than 20 countries and regions around the world. It is expected to attract over 200000 professional visitors.

As a deep cultivator in the field of core raw materials for in vitro diagnostics (IVD), Hubei Xindesheng Materials Technology Co., Ltd. will once again attend the appointment and showcase its five core product series and latest technological achievements at booth 7.1G49. We sincerely invite global partners to explore new paths for industry transition.

Deeply cultivating for 20 years, forging the strength of the entire industry chain

Since its establishment in 2005, Hubei Xindesheng has always adhered to the concept of "craftsmanship, quality, and innovation driven". Starting from Wuhan, it has gradually developed into a high-tech enterprise integrating research and development, production, sales, and service throughout the entire industry chain. The company has a standardized production base in Huanggang with an annual production capacity of 5000 tons and has passed ISO9001 quality management system certification. It can provide customers with comprehensive services from R&D customization to large-scale production.

It is worth noting that in July 2025, the foundation laying ceremony for the new Huanggang factory of Xindesheng was held, and the installation of core equipment was successfully completed. After the completion of the new base, it will significantly enhance the company's production capacity and supply guarantee capabilities in key raw materials such as high-end biological buffering agents, laying a solid foundation for industrial development in the upcoming "15th Five Year Plan" period. In April 2026, the new Huanggang factory will be put into operation.

The thickness of technology determines the height of an enterprise. Xindesheng and Hubei University jointly establish a provincial-level "Enterprise School Joint Innovation and Research Center", holding a total of 23 national patents covering core technologies such as separation medium synthesis, high-sensitivity diagnostic reagents, and bioactive substances. The company has successively been awarded honors such as National High tech Enterprise, Hubei Province Specialized and Innovative Small and Medium sized Enterprise, Hubei Province Science and Technology Innovation "New Species" Gazelle Enterprise, and has been awarded the "Excellent" level in the performance evaluation of new R&D institutions in Hubei Province in 2025, achieving an astonishing comeback from "failing" to "excellent".

Five product series, empowering IVD throughout the entire chain

At this year's CMEF, Xindesheng will comprehensively showcase its full chain raw material solutions covering fields such as biochemical analysis, immune testing, and molecular diagnostics

Chemiluminescence series: Provides core materials for chemiluminescence immunoassay (CLIA) such as acridine esters, luminol derivatives, and magnetic bead coupling reagents, with high sensitivity and suitable for high-precision detection scenarios such as tumor markers and infectious disease screening.

Biological buffer series: more than 20 products including TRIS, HEPES, MOPS, Bicine, Caps, etc., with a purity of over 99.9% and a batch difference of less than 1%. It is widely used in PCR, gene sequencing, cell culture, and pH regulation, with a daily production capacity of up to 5 tons.

Color substrate series: New Trinder's reagents such as TOOS, TOPS, MAOS, ADOS, DA64, DA67, etc., with fast color development speed and low background values, suitable for fully automatic biochemical analyzers and POCT equipment, and supporting customized formulations.

Enzyme preparations: covering various testing items such as cardiovascular markers, infectious disease screening, tumor diagnosis, etc., with high activity, high purity, and high stability as the core advantages.

Innovative fusion, opening a new journey for the 15th Five Year Plan

2026 is the starting year of the 15th Five Year Plan. This year's CMEF closely follows the "15th Five Year Plan" and the Healthy China strategy, focusing on cutting-edge themes such as debut economy, artificial intelligence medical applications, brain computer interfaces, and silver economy. As a key link in the upstream of the IVD industry chain, Xindesheng has always been committed to providing downstream enterprises with high-performance, low-cost, and domestically produced core raw materials. With stable supply chain guarantee capabilities, it helps China's IVD industry achieve a leap in energy level during the "15th Five Year Plan" period.

Meet at 7.1G49 and embark on a new journey together

From April 9th to 12th, at booth 7.1G49 at the Shanghai National Convention and Exhibition Center, the New Desheng technical team will have in-depth discussions with customers on-site, providing one-stop technical support from raw material selection, formula optimization to large-scale production.

Innovative Fusion, Infinite Leap - Hubei Xindesheng cordially invites you to meet in Shanghai and explore the new future of medical technology together!